Arrythmia Research Technology (NYSE:HRT) said on April 9 that Salvatore Emma, Jr. has been named president and CEO of the Fitchburg, Mass.-based medical device company. He was also appointed to the company’s board of directors.
Emma started at Arrhythmia in 2007 and previously worked as an information systems consultant for Munters Corporation, Lawrence Pumps and Convergent Energy.
Kuyper spent 17 years of his career at Aesculap, a subsidiary of B. Braun Medical. He has experience in sales and marketing at various medical device companies and served as a captain in the U.S. Army.
Robert Hureau will take on both roles of CFO and VP at Kinetic Concepts in early May. Hureau spent 6 years at Sensata Technology Holdings, where he worked as controller, CFO, chief accounting officer, and senior VP. He also previously worked at Ocean Spray Cranberries and Coca Cola.
Montgomery will stay on with the company until May 1. The board of directors approved a severance package of $170,186 will be paid out in equal installments.
Insmed named Matthew Pauls chief commercial officer, a newly created role. The Monmouth Junction, N.J.-based company created this position to oversee global commercial activities for its Arikace device for cystic fibrosis and lung infection patients.